

Healthcare Goes Digital
Impetus Digital
We are covering topics on tissue 3D bioprinting, clinical trials in silica, quantum computing in product development, blockchain-powered patient management portals, nanotechnologies, and digital therapeutics. We are also covering topics on leadership in the new pharma paradigm post-COVID-19 and what it will mean to function in the new virtual world we find ourselves in. We will be asking how pharma business models will need to change and what new partnerships will need to develop as a result of this pandemic. At Impetus Digital, we believe all new, great ideas start with a conversation. Building on each other's ideas over time. One step at a time. This is how we believe positive disruption will occur. At Impetus Digital, we are leaders in delivering virtual collaboration experiences for life sciences companies. We offer the most comprehensive virtual meeting and event tools and services on the market. The Impetus InSite Platform® is a turn-key software solution that enables a “long-game” approach in connecting brands with key stakeholders, both synchronously and asynchronously. Its customizable, multilingual interface and its robust, pharma-compliant security make it the ideal choice for authentic engagement. Founded in 2008, we have over a decade of experience in virtualizing meetings and events. We offer a full range of strategic, medical writing, and digital services to help make the transition to hybrid events seamless. Visit our website www.impetusdigital.com to learn more!
Episodes
Mentioned books

Dec 2, 2020 • 57min
The Future of Wearable and Implantable Devices with Nance Dicciani and Denise Devine, Co-founders of RTM Vital Signs
Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. They explore continuous ambulatory vital sign monitoring using wearable and implantable devices. Among many other things, they dive deeper into the many use cases, benefits, and barriers to these...To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalNance Dicciani: https://www.linkedin.com/in/nance-k-dicciani-83186415/Denise Devine: https://www.linkedin.com/in/denise-l-devine-6a9978/RTM Vital Signs: https://rtmvitalsigns.com/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital

Dec 1, 2020 • 60min
Designing Ethical AI and Healthcare Technologies with Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics
Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics, wearables, big data and data analytics, and more. We also delve into the novel ethical dilemmas brought on by the COVID-19 pandemic and how these can be managed.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalBryn Williams-Jones: https://www.linkedin.com/in/brynwilliamsjones/?originalSubdomain=caESPUM: http://espum.umontreal.ca/Canadian Journal of Bioethics: http://cjb-rcb.ca/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital

Nov 27, 2020 • 36min
Attacking COVID-19 from All Angles with Michael Taylor, CEO & Founder of Environmental Surface Solutions
Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating but also protecting facilities from future contamination.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalMichael Taylor: https://www.linkedin.com/in/michael-taylor-3b9061200/Environmental Surface Solutions: https://www.environmentalsurfacesolutions.com/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital

Nov 24, 2020 • 1h 2min
Importance of Patient Advocacy in Improving Healthcare with Eva Villalba, Executive Director of Coalition Priorité Cancer au Québec
Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support people affected by cancer, the concept of “value-based healthcare,” and what needs to happen to make clinical trials truly patient-centric.Schedule a meeting with Natalie Yeadon: https://www.meetwithnatalie.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalEva Villalba: https://www.linkedin.com/in/evavillalba1/?locale=en_USCoalition Priorité Cancer au Québec: http://coalitioncancer.com/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital

Nov 23, 2020 • 59min
Improving Patient Care by Removing Barriers to Drug Accessibility with Alan Birch, Founder & President of Drug Access Canada
Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and whether digital technologies can be used to overcome these challenges.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalAlan Birch: https://www.linkedin.com/in/alan-birch-85b6842b/Drug Access Canada: http://www.drugaccess.ca/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital

Nov 20, 2020 • 56min
Reimagining the Patient Journey with Kimberly Tableman, CEO at Medicine X
Kimberly Tableman, CEO at Medicine X, discusses a myriad of topics related to digital transformation and patient centricity, including how digital health technologies can be used to reimagine the patient journey.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalKimberly Tableman: https://www.linkedin.com/in/kimberly-tableman-501309/Medicine X: http://www.medicinex.com/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital

Nov 19, 2020 • 59min
Leadership Lessons Learned from the Pandemic with Alok Kanti, President & CEO at Bayer Canada
Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health technologies play the biggest roles in the new normal.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalAlok Kanti: https://www.linkedin.com/in/alok-kanti-675755108/Bayer Canada: https://www.bayer.ca/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital

Nov 5, 2020 • 53min
Commercial Execution Strategies During & After the Pandemic with Frank Armenante, Director of Commercial Execution at Novo Nordisk
Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons and tips for creating company culture in this increasingly virtual world.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalFrank Armenante: https://www.linkedin.com/in/frank-armenante-01079a/Novo Nordisk: https://www.novonordisk.com/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital

Oct 28, 2020 • 1h
Pharma, Technology and Healthcare in the New Normal with Brian Canestraro, General Manager at Intercept Pharmaceuticals
Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses a range of hot topics, from Brian’s leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with HCPs and patients. We also explore subjects such as patient-centricity, how Pharma’s business model will change in the future, and the role of digital technologies in clinical trials and medical education.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalBrian Canestraro: https://www.linkedin.com/in/brian-canestraro-42015412/Intercept Pharmaceuticals: http://www.interceptpharma.com/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital

Oct 26, 2020 • 58min
Therapeutic VR for Managing Pain & Improving Patient Outcomes with Ramsay Brown, CEO and Founder of Quol
Ramsay Brown, CEO and Founder of Quol, delves into several different HealthTech topics, including the concept of VR therapeutics and the importance of incorporating behavioral science and neuroscience into VR solutions, as well as how the COVID-19 pandemic has affected the HealthTech industry.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalRamsay Brown: https://www.linkedin.com/in/ramsaybr/Quol: http://www.quol.design/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital


